Vol 58, No Supplement 10 | The Journal of Clinical Psychiatry

Article

The Application of Neuroimaging Techniques to Drug Development

J Clin Psychiatry 1997;58(suppl 10):3-6

Carol A. Tamminga, M.D. ; Robert R. Conley, M.D.

Article

Efficacy of Olanzapine: An Overview of Pivotal Clinical Trials

J Clin Psychiatry 1997;58(suppl 10):7-12

Charles M. Beasley, Jr., M.D. ; Gary D. Tollefson, M.D., Ph.D. ; Pierre V. Tran, M.D.

Article

Safety of Olanzapine

J Clin Psychiatry 1997;58(suppl 10):13-17

Charles M. Beasley, Jr., M.D. ; Gary D. Tollefson, M.D., Ph.D. ; Pierre V. Tran, M.D.

Article

Olanzapine and the New Generation of Antipsychotic Agents: Patterns of Use

J Clin Psychiatry 1997;58(suppl 10):18-21

William M. Glazer, M.D.

Article

The Biological Basis of Schizophrenia: New Directions

J Clin Psychiatry 1997;58(suppl 10):22-27

Daniel R. Weinberger, M.D.

Article

In Vitro and In Vivo Biochemistry of Olanzapine: A Novel, Atypical Antipsychotic Drug

J Clin Psychiatry 1997;58(suppl 10):28-36

Frank P. Bymaster, M.S. ; Kurt Rasmussen, Ph.D. ; David O. Calligaro, Ph.D. ; David L. Nelson, Ph.D. ; Neil W. DeLapp, Ph.D. ; David T. Wong, Ph.D. ; Nicholas A. Moore, Ph.D.

Article

Behavioral Pharmacology of Olanzapine: A Novel Antipsychotic Drug

J Clin Psychiatry 1997;58(suppl 10):37-44

Nicholas A. Moore, Ph.D. ; J. David Leander, Ph.D. ; Mark J. Benvenga, M.S. ; Scott D. Gleason ; Harlan Shannon, Ph.D.

Article

Dosing the Antipsychotic Medication Olanzapine

J Clin Psychiatry 1997;58(suppl 10):45-49

Charles B. Nemeroff, M.D., Ph.D.

Article

Pharmacoeconomic Evaluation of Antipsychotic Therapy for Schizophrenia

J Clin Psychiatry 1997;58(suppl 10):50-54

William M. Glazer, M.D. ; Bryan M. Johnstone, Ph.D.

Article

The Relationship of Pharmacology to Side Effects

J Clin Psychiatry 1997;58(suppl 10):55-62

Daniel E. Casey, M.D.

Article

Switching Antipsychotic Medications

J Clin Psychiatry 1997;58(suppl 10):63-72

Peter J. Weiden, M.D. ; Ralph Aquila, M.D. ; Laura Dalheim, M.D. ; Janet M. Standard, R.N.

Article

Concluding Remarks

J Clin Psychiatry 1997;58(suppl 10):63-72

Gary D. Tollefson, M.D., Ph.D.

Volume 58 • 1997 • Supplement 10

Article

The Application of Neuroimaging Techniques to Drug Development

Efficacy of Olanzapine: An Overview of Pivotal Clinical Trials

Safety of Olanzapine

Olanzapine and the New Generation of Antipsychotic Agents: Patterns of Use

The Biological Basis of Schizophrenia: New Directions

In Vitro and In Vivo Biochemistry of Olanzapine: A Novel, Atypical Antipsychotic Drug

Behavioral Pharmacology of Olanzapine: A Novel Antipsychotic Drug

Dosing the Antipsychotic Medication Olanzapine

Pharmacoeconomic Evaluation of Antipsychotic Therapy for Schizophrenia

The Relationship of Pharmacology to Side Effects

Switching Antipsychotic Medications

Concluding Remarks

ELSEWHERE:

FOLLOW US:

Volume 58 • 1997 • Supplement 10

Article

The Application of Neuroimaging Techniques to Drug Development

Efficacy of Olanzapine: An Overview of Pivotal Clinical Trials

Safety of Olanzapine

Olanzapine and the New Generation of Antipsychotic Agents: Patterns of Use

The Biological Basis of Schizophrenia: New Directions

In Vitro and In Vivo Biochemistry of Olanzapine: A Novel, Atypical Antipsychotic Drug

Behavioral Pharmacology of Olanzapine: A Novel Antipsychotic Drug

Dosing the Antipsychotic Medication Olanzapine

Pharmacoeconomic Evaluation of Antipsychotic Therapy for Schizophrenia

The Relationship of Pharmacology to Side Effects

Switching Antipsychotic Medications

Concluding Remarks

Watch the New PsychCase360

Subscribe to readmore articles

Subscribe to read
more articles